FIG
MACK

Fortress Investment Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Fortress Investment Group’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-23,169
Closed -$693K – 205
2013
Q3 		$693K Buy
23,169
+3,087
+15% +$108K 0.01% 103
2013
Q2 		$1.06M Buy
+20,082
New +$880K 0.03% 65

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fortress Investment Group's MACK Position: Q4 2013 in Review

Fortress Investment Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2013, closing a stake of 23,169 shares — an estimated $693K sold.

Fortress Investment Group first reported a position in MACK in Q2 2013 and held it in 2 quarters. The position peaked at $1.06M in Q2 2013. 93 funds tracked by Wall St. Rank hold MACK as of Q4 2013.

  • Fortress Investment Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Fortress Investment Group sold 23,169 Merrimack Pharmaceuticals, Inc. shares in Q4 2013, an estimated $693K.
  • Fortress Investment Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Fortress Investment Group's Merrimack Pharmaceuticals, Inc. position peaked at $1.06M in Q2 2013.
  • 93 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2013.

Based on Fortress Investment Group's 13F filing for Q4 2013, filed 14 Feb 2014.